Read, pause, explore
Semaglutide
Also listed as Wegovy
A reference to read with the sources beside you.
Status as of . The reference fields below define the scope of these labels.
Filed under Metabolism for browsing.
Reference fields
Sources for these fields- Approval scope
- Wegovy injection: weight management in eligible adults.
- Route and formulation
- This entry covers subcutaneous Wegovy injection.
- Mechanism
- Activates the GLP-1 receptor.
- Evidence
- Randomized trials.
- Limits of the evidence
- Check other products separately.
- Safety context
- Severe or persistent gastrointestinal symptoms: contact a clinician.
A closer reading
Make space for the question
A short summary can be accurate and still leave out much of the pattern. Imagine a report that gives an average score but never shows how widely the individual scores differ. A tightly clustered set and a widely scattered set could share that average, yet tell different stories about variation. Looking for the spread gives the headline some shape. It also leaves room for experiences that do not resemble the center. The useful next step is to ask what the summary preserves, what it compresses, and whether the missing detail matters to the claim being made.
Keep these questions nearby
- What information about variation disappears when the report presents only an average?
- Could very different patterns of results produce the same headline summary?
- Which additional display would help explain how the individual observations are distributed?
Sources
The references below accompany the entry as a whole. Dates show when each source was checked.
- WEGOVYNLM · Checked
- Wegovy approvalFDA · Checked
Keep a little room for reading
For a longer discussion of how research is interpreted, open the companion scientific analysis.
Prepared by Healthy Pound Editorial Team. Educational reference; no clinical review is claimed. This page does not provide individual medical advice.